Get started
RocketTickers

FDA Approves New Dupixent® (dupilumab) Pre-filled Pen Designed t

Long
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)  
RocketTickers  
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
Beyond Technical Analysis
6
0
beyondta
REGN: Regeneron Pharmaceuticals, Inc.
2020-06-19 13:44:00
FDA Approves New Dupixent® (dupilumab) Pre-filled Pen Designed to Support More Convenient Self-Administration
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.